Associate Director/Sr. Manager, Health Economics & Outcomes Research-Oncology

Position Summary

We are seeking a strategic, analytical, and highly collaborative leader to serve as our

Associate Director/Senior Manager of Health Economics & Outcomes Research

(HEOR) Oncology. In this high-impact role, you will lead the development and execution

of health economic and outcomes evidence demonstrating the clinical and economic

value of Natera’s precision molecular diagnostic technologies across oncology and

emerging indications.

You will develop health economic models, generate real-world and clinical-trial

evidence, lead HEOR publication initiatives, and translate complex clinical and

economic data into compelling evidence supporting market access, reimbursement,

payer adoption, clinical adoption, and commercialization. Working across Medical

Affairs, Clinical Development, Biostatistics, Market Access, Commercial, Marketing,

Regulatory, and Business Development, you will help integrate HEOR evidence

throughout the product lifecycle—from clinical development and evidence generation

through publication, reimbursement, and payer adoption.

This is a strategic role for an experienced HEOR professional who combines strong

technical capabilities with scientific communication, business acumen, and the ability to

influence cross-functional evidence strategy.

Why Join Us

At Natera, you will have the opportunity to shape the economic evidence strategy

supporting innovative precision diagnostics and biomarker-guided approaches to patient

care. You will work at the intersection of clinical evidence, health economics, market

access, and commercialization, translating clinical innovation into measurable value for

patients, providers, health systems, and payers.

You will collaborate with internal leaders, investigators, key opinion leaders, and

external research partners to generate evidence capable of influencing reimbursement

decisions, clinical adoption, health technology assessments, and healthcare policy

across U.S. and global markets.

Key Responsibilities

 Health Economic Modeling & Value Demonstration: Lead the development,

validation, and application of health economic models, including budget impact,

cost-effectiveness, cost-utility, cost-consequence, ROI, decision-tree,

Markov/state-transition, partitioned-survival, and other economic models.

Develop scenario and sensitivity analyses that quantify the clinical and economic

value of precision diagnostics across different payer and healthcare-system

perspectives.

 Clinical Development & HEOR Evidence Strategy: Partner with Clinical

Development, Medical Affairs, Biostatistics, and other cross-functional teams to

integrate HEOR objectives into prospective clinical studies, including healthcare

resource utilization, economic endpoints, patient-reported outcomes, quality-of-

life measures, cost-data collection, and real-world evidence strategies. Ensure

evidence-generation plans anticipate future payer, reimbursement, and HTA

requirements.

 Real-World Evidence & Outcomes Research: Analyze clinical-trial,

observational, and real-world datasets to evaluate healthcare resource utilization,

cost of care, treatment pathways, diagnostic utilization, clinical utility, comparative

effectiveness, patient outcomes, survival, budget impact, and quality-adjusted life

years. Translate findings into actionable evidence supporting clinical, payer, and

business decisions.

 Publication & Scientific Evidence Leadership: Lead HEOR publication

strategy and development of peer-reviewed manuscripts, scientific abstracts,

conference posters, oral presentations, white papers, and technical reports.

Coordinate publication plans and timelines with investigators, key opinion

leaders, academic collaborators, and external research partners to ensure

evidence generation is aligned with strategic business priorities.

 Market Access & Payer Evidence: Partner with Market Access, Medical Affairs,

Marketing, and Commercial teams to translate HEOR evidence into payer value

propositions, budget impact summaries, value dossiers, reimbursement

materials, health economic briefs, health-system value calculators, account-

specific economic tools, and other evidence-based value communications.

 Global HEOR Strategy: Develop and adapt health economic evidence and

payer models for the U.S. and international markets, including Europe, Japan,

Canada, Australia, and other priority geographies. Support reimbursement

submissions and evidence strategies aligned with HTA and payer requirements

across healthcare systems.

 Cross-Functional & External Collaboration: Serve as a strategic HEOR

partner across Medical Affairs, Clinical Development, Biostatistics, Market

Access, Commercial, Marketing, Regulatory, and Business Development.

Collaborate with external consultants, academic investigators, KOLs, and

research partners to execute high-quality evidence-generation initiatives.

Core Skills & Competencies

 Health Economics & Outcomes Research: Deep understanding of health

economic modeling, outcomes research, healthcare resource utilization, real-

world evidence, cost-of-care analysis, comparative effectiveness, and value

assessment methodologies.

 Economic Modeling: Demonstrated ability to develop and critically evaluate

budget impact, cost-effectiveness, cost-utility, ROI, decision-tree, Markov/state-

transition, and related economic models.

 Payer & Market Access Strategy: Strong understanding of payer evidence

requirements and the ability to translate clinical and economic evidence into

compelling value propositions supporting reimbursement, coverage, and

adoption.

 Evidence Generation & Clinical Strategy: Ability to integrate HEOR endpoints

and evidence requirements into clinical development and real-world research

programs, anticipating future reimbursement and HTA needs.

 Scientific Communication & Publication: Strong scientific writing and

communication skills with experience translating complex analyses into

manuscripts, abstracts, presentations, value dossiers, payer materials, and

executive-level communications.

 Cross-Functional Leadership: Proven ability to work across clinical, medical,

statistical, market access, commercial, and business functions and to influence

evidence strategy in a matrixed organization.

 Global Perspective: Understanding of U.S. and international reimbursement

environments and major HTA frameworks, including ICER, NICE, CADTH,

PBAC, IQWiG, and Japanese reimbursement processes.

Qualifications

 Advanced degree (PhD, PharmD, MD, DrPH, or Master‘s degree) in Health

Economics, Outcomes Research, Epidemiology, Public Health, Biostatistics,

Pharmacy, Health Services Research, or a related discipline.

 5–10+ years of HEOR experience within biotechnology, pharmaceuticals,

diagnostics, medical devices, consulting, academia, or a related healthcare

environment.

 Demonstrated experience developing and applying health economic models and

conducting outcomes research using clinical-trial and/or real-world datasets.

 Experience supporting payer evidence generation, reimbursement strategy, value

dossiers, market access initiatives, and scientific publications.

 Experience with precision medicine, molecular diagnostics, companion

diagnostics, ctDNA, molecular residual disease (MRD), donor-derived cell-free

DNA (dd-cfDNA), next-generation sequencing, biomarker-guided treatment

strategies, or oncology diagnostics is highly desirable.

 Familiarity with advanced economic and analytical tools such as Microsoft Excel,

TreeAge Pro, R, SAS, STATA, Python, SQL, Tableau/Power BI, and statistical

analysis software is preferred.

The pay range is listed and actual compensation packages are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications and specific office location. This may differ in other locations due to cost of labor considerations.

Remote USA

$157,000—$218,000 USD

Compensation & Total Rewards

This range reflects a good-faith estimate of the base pay we reasonably expect to offer at the time of hire. Final compensation will vary based on experience, qualifications, and internal equity considerations.

This position is also eligible for additional compensation and benefits through Natera’s robust Total Rewards program, including:

• Annual performance incentive bonus

• Long-term equity awards

• Comprehensive health benefits (medical, dental, vision)

• 401(k) with company match

• Generous paid time off and company holidays

• Additional wellness and work-life benefits

Compensation Range

$191,800—$239,800 USD

OUR OPPORTUNITY

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.

The Natera team consists of highly dedicated statisticians, geneticists, doctors, laboratory scientists, business professionals, software engineers and many other professionals from world-class institutions, who care deeply for our work and each other. When you join Natera, you’ll work hard and grow quickly. Working alongside the elite of the industry, you’ll be stretched and challenged, and take pride in being part of a company that is changing the landscape of genetic disease management.

WHAT WE OFFER

Competitive Benefits - Employee benefits include comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents. Additionally, Natera employees and their immediate families receive free testing in addition to fertility care benefits. Other benefits include pregnancy and baby bonding leave, 401k benefits, commuter benefits and much more. We also offer a generous employee referral pr